Results 21 to 30 of about 41,916 (253)
Scientific Reports, 2021 While vaccines remain the best tool for preventing influenza virus infections, they have demonstrated low to moderate effectiveness in recent years. Seasonal influenza vaccines typically consist of wild-type influenza A and B viruses that are limited in ...
James D. Allen, T. Ross
semanticscholar +1 more source
Viruses, 2022 Prior vaccination can alternately enhance or attenuate influenza vaccine immunogenicity and effectiveness. Analogously, we found that vaccine immunogenicity was enhanced by prior A(H3N2) virus infection among participants of the Ha Nam Cohort, Viet Nam ...
A. Fox +12 more
semanticscholar +1 more source
Influenza vaccine effectiveness against A(H3N2) during the delayed 2021/22 epidemic in Canada
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2022 Influenza virus circulation virtually ceased in Canada during the COVID-19 pandemic, re-emerging with the relaxation of restrictions in spring 2022. Using a test-negative design, the Canadian Sentinel Practitioner Surveillance Network reports 2021/22 ...
S. Kim +11 more
semanticscholar +1 more source
Journal of Health Science and Medical Research (JHSMR), 2021 Objective: This study aims to describe the clinical, laboratory and electrophysiological findings of the prisoners who developed acute reversible motor predominant polyradiculoneuropathy after the outbreak of H3N2 influenza.
Phichamon Khanittanuphong +7 more
doaj +1 more source
Egg-adaptive mutations of human influenza H3N2 virus are contingent on natural evolution
PLoS Pathogens, 2022 Egg-adaptive mutations in influenza hemagglutinin (HA) often emerge during the production of egg-based seasonal influenza vaccines, which contribute to the largest share in the global influenza vaccine market.
Weiwen Liang +7 more
semanticscholar +1 more source
Rapport national de mi-saison sur l’influenza au Canada, 2020–2021
Canada Communicable Disease Report, 2021 Au Canada, la saison nationale de la grippe commence généralement dans la seconde moitié du mois de novembre (semaine 47) et elle est définie comme la semaine où au moins 5 % des tests de grippe sont positifs et où un minimum de 15 tests positifs sont ...
Liza Lee +5 more
doaj +1 more source
Subtype H3N2 Influenza A Viruses: An Unmet Challenge in the Western Pacific
Vaccines, 2022 Subtype H3N2 influenza A viruses (A(H3N2)) have been the dominant strain in some countries in the Western Pacific region since the 2009 influenza A(H1N1) pandemic.
Min Kang, Mark Zanin, Sook-san Wong
semanticscholar +1 more source
Study of the host specificity of PB1-F2-associated virulence
Virulence, 2021 Influenza A viruses cause important diseases in both human and animal. The PB1-F2 protein is a virulence factor expressed by some influenza viruses.
Joëlle Mettier +5 more
doaj +1 more source
N-Linked Glycosylation Attenuates H3N2 Influenza Viruses [PDF]
Journal of Virology, 2007 ABSTRACT Over the last four decades, H3N2 subtype influenza A viruses have gradually acquired additional potential sites for glycosylation within the globular head of the hemagglutinin (HA) protein. Here, we have examined the biological effect of additional glycosylation on the virulence of H3N2 influenza viruses. We created otherwise
Vigerust, David J. +5 more
openaire +3 more sources
National Influenza Mid-Season Report, 2019–2020
Canada Communicable Disease Report, 2020 Canada’s national influenza season started in week 47 between November 17 to 23, 2019. Of the 3,762 laboratory-confirmed influenza detections reported from August 25 to December 14, 2019, 61% were influenza A, and of those subtyped, 68% were A(H3N2 ...
Claire Sevenhuysen +7 more
doaj +1 more source